HTG Molecular Diagnostics, Inc. announced the appointment of Maureen T. Cronin as the company’s Chief Scientific Officer and Senior Vice President as of November 16, 2018. Dr. Cronin is a veteran biotechnology, translational science and diagnostic executive. Dr. Maureen Cronin’s brings to HTG extensive experience in genomic technology development, laboratory test development and delivery, regulatory compliance, academic clinical research and pharmaceutical company therapeutics development. Previously, Dr. Cronin was Executive Director of Strategic Information Management for Celgene Corporation, a global biopharmaceutical company engaged in the discovery, development, and commercialization of innovative therapies for the treatment of cancer and inflammatory diseases, from 2012 to 2017. Prior to Celgene, she was Senior Vice President of Research and Product Development for Foundation Medicine, Inc., a molecular oncology diagnostics company, from 2010 to 2012. At Genomic Health, Inc., also a molecular oncology diagnostics company, Dr. Cronin was Vice President of Translation Research from 2004 to 2010 and Senior Director of Technology Development from 2001 to 2004.